Real world data of CAPTEM in metastatic neuroendocrine tumors

#3915

Introduction: Neuroendocrine tumors (NET) are commonly treated with multimodality therapy.

Aim(s): The study aimed to evaluate patients' outcomes and prognosis with metastatic NET who were treated with CAPTEM as well as the safety of the regimen.

Materials and methods: Retrospective, single-center study, which included patients with NET, treated with CAPTEM between January 2019 and March 2023. Clinicopathological, treatment and tolerability data were collected. Sifnificance was set for p<0,05.

Conference:

Presenting Author:

Authors: Ramos M, Barbosa A, Azevedo I, Rodrigues A, Silva J,

Keywords: CAPTEM, NET, Real-world data,